New drug AWT020 takes on advanced solid tumors
NCT ID NCT06839105
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This phase 1 trial tests a new drug called AWT020, given alone or with other cancer treatments, in people with advanced solid tumors such as non-small cell lung cancer, colorectal cancer, kidney cancer, and melanoma. The main goals are to check the drug's safety, find the best dose, and see if it helps shrink tumors. Participants must have tried standard treatments without success or have no standard options available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AWT020
What this could lead to
If safe and effective, AWT020 could become a new treatment option for people with advanced cancers that have not responded to standard therapies.
What could go wrong
This is an early phase 1 trial with a small number of participants, so the drug may not prove effective or may cause unexpected side effects. Success in this phase does not guarantee later approval.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver Fibrosis in HIV-HBV Patients: NCT02344680
- 68Ga-FAPI-46 PET Imaging in Cancer Patients (NCT07118176)
- Contrast Ultrasound vs. MRI for HCC Detection (NCT06184152)
- Liver Cancer Navigation Trial NCT06260943
- Combination Therapy for High-Risk Rectal Cancer NCT06908031
- Rectal Cancer Trial: Bevacizumab + Chemo Before NCT01871571
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Fujian Cancer Hospital
RECRUITINGFuzhou, Fujian, 350014, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Harbin Medical University Cancer Hospital
NOT_YET_RECRUITINGHarbin, Heilongjiang, 150081, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hubei Cancer Hospital
RECRUITINGWuhan, Hubei, 430079, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, 410000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Liaoning Cancer Hospital & Institute
NOT_YET_RECRUITINGShenyang, Liaoning, 110042, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Shanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sun Yat-sen University Cancer Center
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510060, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The First Affiliated Hospital of Henan University of Science & Technology
NOT_YET_RECRUITINGLuoyang, Henan, 471099, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The First Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 400042, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The First Hospital of Jilin University
NOT_YET_RECRUITINGChangchun, Jilin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Yunnan Cancer Hospital
NOT_YET_RECRUITINGKunming, Yunnan, 650118, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Zhejiang Cancer Hospital
NOT_YET_RECRUITINGHangzhou, Zhejiang, 310022, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact